Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome

Coronary Artery Disease

Volumn 19, Issue 3, 2008, Pages 125-131

  Onat, Altan ^a,b,g   Hergenç, Gülay ^c   Özhan, Hakan ^d   Kaya, Zekeriya ^e   Bulur, Serkan ^d   Ayhan, Erkan ^f   Can, Günay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^d Cardiology Department   (Turkey)

^e Kosuyolu Heart Center   (Turkey)

^f DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^g NONE   (Turkey)

Author keywords

Coronary heart disease; Insulin resistance; Lipoprotein(a); Metabolic syndrome

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEPHELOMETRY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TURKEY (REPUBLIC);

AGED; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TURKEY;

EID: 42349088393     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f399cf     Document Type: Article

References (30)

1. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90:52-60.
2. Utermann G, Menzel H, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a) lipoprotein concentrations in plasma. J Clin Invest 1987; 80:458-465.
3. McLean J, Tomlinson J, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330:132-137.
4. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 2000; 102:1082-1085.
5. Marcovina SM, Albers JJ, Jacobs DR Jr, Perkins LL, Lewis CE, Howard BV, Savage P. Lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler Thromb 1993; 13:1037-1045.
6. Onat A, Ceyhan K, Basar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165:285-292.
7. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156:1-10.
8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
9. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160-3167.
10. Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006; 55:445-452.
11. Mather KJ, Hunt AE, Steinber HO, Paradisi G, Hook G, Katz A, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86:5457-5464.
12. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed. Geneva: WHO; 1982. pp. 124-127.
13. Mahley RW, Palaolu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36:839-859.
14. Hergenç G, Özsüllü T, Çetinalp P, Besoluk S, Befloluk FI, Sönmez B. Lp(a) levels in men with coronary artery occlusion and healthy male controls. Biochem Soc Trans 1999; 27:A1222.
15. Adam B, Talu C, Bedir A, Alvur M, Sagkan O. The levels of lipids, lipoproteins and apolipoproteins in healthy people in the central region of the Black Sea. Jpn Heart J 1999; 40:427-434.
16. Örem A, Deger O, Kulan K, Onder E, Kiran E, Uzunosmanoglu D. Evaluation of lipoprotein(a) [Lp(a)] as a risk factor for coronary artery disease in the Turkish population. Clin Biochem 1995; 28:171-173.
17. Duell PB, Hagemenas F, Connor WE. The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care 1994; 17:1135-1140.
18. Haffner SM, Gruber KK, Morales PA, Hazuda HP, Valdez RA, Mitchell BD, Stern MP. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol 1992; 136:1060-1068.
19. Inoue K, Nago N, Matsuo H, Goto T, Miyamoto T, Saegusa T, et al. Serum insulin and lipoprotein(a) concentrations. Diabetes Care 1997; 20:1242-1247.
20. Haffner SM, Karhapaa P, Rainwater DL, Mykkanen L, Aldrete G Jr, Laakso M. Insulin sensitivity and Lp(a) concentrations in normoglycemic men. Diabetes Care 1995; 18:193-199.
21. Rainwater DL, Haffner SM. Insulin and 2-h glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol 1998; 18:1335-1341.
22. Nielsen LB. Atherogenicity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux. Atherosclerosis 1999; 143:229-243.
23. Syrovets T, Thillet J, Chapman MJ, Simmet T. Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes. Blood 1997; 90:2027-2036.
24. Takami S, Yamashita S, Kihara S, Ishigami M, Takemura K, Kume N, et al. Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. Circulation 1998; 97:721-728.
25. Von Depka M, Nowak-Göttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, et al. Increased lipoprotein(a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96:3364-3368.
26. Nowak-Göttl U, Junker R, Kreuz W, von Eckardstein A, Kosch A, Nohe N, et al. Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97:858-862.
27. Chien K-L, Lee Y-T, Sung F-C, Su T-C, Hsu H-C, Lin R-S. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. Atherosclerosis 1999; 143:267-273.
28. Onat A, Yazici M, Hergenc G, Dogan Y, Karabulut A, Sari I, et al. Lipoprotein (a) in a population-based study: more significant in Turkish women than men? Anadolu Kardiyol Derg 2005; 5:271-277.
29. Dalpino F, Sodre FL, Castilho LN, de Faria EC. Determinants of serum lipoprotein(a) concentration in normolipidaemic individuals without clinical atherosclerosis. Ann Clin Biochem 2005; 42:398-399.
30. Onat A, Hergenc G, Karabulut A, Turkmen S, Dogan Y, Uyarel H, et al. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med 2006; 43:136-139.